Patients with pericarditis may be on various medications to prevent episodes from recurring. Dr. Allan Klein, Director of Cleveland Clinic’s Pericardial Disease Center, provides the results of the RHAPSODY trial that looked at a new medication (Rilonacept) vs. placebo for patients with pericarditis. He talks about the exciting results of this study and what this may mean for patients in the future.